Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia.

Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Cappelletti J, van Kammen DP, King AC, Johnson JL, Manning RG, Flynn RW, Mann LS, Bunney WE Jr, Sokoloff L.

Arch Gen Psychiatry. 1982 Mar;39(3):251-9.

PMID:
6978119
2.

Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders.

Buchsbaum MS, DeLisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J, et al.

Arch Gen Psychiatry. 1984 Dec;41(12):1159-66.

PMID:
6334502
3.

Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.

Farkas T, Wolf AP, Jaeger J, Brodie JD, Christman DR, Fowler JS.

Arch Gen Psychiatry. 1984 Mar;41(3):293-300.

PMID:
6608333
4.

Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography.

Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S.

Br J Psychiatry. 1990 Feb;156:216-27.

PMID:
2317626
5.

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.

Wolkin A, Jaeger J, Brodie JD, Wolf AP, Fowler J, Rotrosen J, Gomez-Mont F, Cancro R.

Am J Psychiatry. 1985 May;142(5):564-71.

PMID:
3872603
6.
7.

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.

Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, King AC, Hazlett E, Langston K, Post RM.

J Affect Disord. 1986 Mar-Apr;10(2):137-52.

PMID:
2941470
8.

Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.

Siegel BV Jr, Buchsbaum MS, Bunney WE Jr, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG, et al.

Am J Psychiatry. 1993 Sep;150(9):1325-36.

PMID:
8352343
9.

Regional brain function in schizophrenia. I. A positron emission tomography study.

Gur RE, Resnick SM, Alavi A, Gur RC, Caroff S, Dann R, Silver FL, Saykin AJ, Chawluk JB, Kushner M, et al.

Arch Gen Psychiatry. 1987 Feb;44(2):119-25.

PMID:
3492982
10.

Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients.

DeLisi LE, Buchsbaum MS, Holcomb HH, Dowling-Zimmerman S, Pickar D, Boronow J, Morihisa JM, van Kammen DP, Carpenter W, Kessler R, et al.

Am J Psychiatry. 1985 Jan;142(1):78-81.

PMID:
3871312
11.

Positron emission tomographic image measurement in schizophrenia and affective disorders.

Buchsbaum MS, Cappelletti J, Ball R, Hazlett E, King AC, Johnson J, Wu J, DeLisi LE.

Ann Neurol. 1984;15 Suppl:S157-65.

PMID:
6611116
12.

Cerebral metabolic consequences of electrical cutaneous stimulation in normal individuals.

Buchsbaum MS, Holcomb HH, Johnson J, King AC, Kessler R.

Hum Neurobiol. 1983;2(1):35-8.

PMID:
6603452
13.

Brain glucose metabolism in violent psychiatric patients: a preliminary study.

Volkow ND, Tancredi LR, Grant C, Gillespie H, Valentine A, Mullani N, Wang GJ, Hollister L.

Psychiatry Res. 1995 Nov 10;61(4):243-53.

PMID:
8748468
14.

Metabolic subtypes in patients with schizophrenia.

Clark CM, Kopala L, James G, Hurwitz T, Li D.

Biol Psychiatry. 1993 Jan 15;33(2):86-92.

PMID:
8439608
15.

Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia.

Cleghorn JM, Garnett ES, Nahmias C, Firnau G, Brown GM, Kaplan R, Szechtman H, Szechtman B.

Psychiatry Res. 1989 May;28(2):119-33.

PMID:
2787515
16.

Increased temporal lobe glucose use in chronic schizophrenic patients.

DeLisi LE, Buchsbaum MS, Holcomb HH, Langston KC, King AC, Kessler R, Pickar D, Carpenter WT Jr, Morihisa JM, Margolin R, et al.

Biol Psychiatry. 1989 Apr 1;25(7):835-51.

PMID:
2785820
17.

[No hypofrontality in schizophrenia demonstrated by positron emission tomography].

Biver F, Delvenne V, Goldman S, Luxen A, De Maertelaer V, Lotstra F, Mendlewicz J.

Acta Psychiatr Belg. 1992 Sep-Oct;92(5):261-78. Review. French.

PMID:
1345405
18.

Low frontal glucose utilization in chronic schizophrenia: a replication study.

Wolkin A, Angrist B, Wolf A, Brodie JD, Wolkin B, Jaeger J, Cancro R, Rotrosen J.

Am J Psychiatry. 1988 Feb;145(2):251-3.

PMID:
3257653
19.

Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.

Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, et al.

Arch Gen Psychiatry. 1992 Dec;49(12):935-42.

PMID:
1360198
20.

Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography.

Gur RE, Resnick SM, Gur RC, Alavi A, Caroff S, Kushner M, Reivich M.

Arch Gen Psychiatry. 1987 Feb;44(2):126-9.

PMID:
3492983

Supplemental Content

Support Center